Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating microRNAs targeting coagulation and fibrinolysis in patients with severe COVID-19

5 Sept 2024

Abstract excerpt

BACKGROUND: Coronavirus-19 disease (COVID-19) frequently causes coagulation disturbances. Data remains limited on the effects of microRNAs (miRNAs) on coagulation during COVID-19 infection. We aimed to analyze the comprehensive miRNA profile as well as coagulation markers and blood count in hospitalized COVID-19 patients. METHODS: Citrated plasma samples from 40 patients (24 men and 16 women) hospitalized for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Extracellular vesicles in disease
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39237986
DOI: 10.1186/s12959-024-00649-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating microRNAs targeting coagulation and fibrinolysis in patients with severe COVID-19PMID 39237986Read ↗

Interrelationship between COVID-19 and coagulopathy: pathophysiological and clinical evidenceSemantic proximity Read ↗

Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patientsSemantic proximity Read ↗

Severity-stratified and longitudinal analysis of VWF/ADAMTS13 imbalance, altered fibrin crosslinking and inhibition of fibrinolysis as contributors to COVID-19 coagulopathySemantic proximity Read ↗

Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review.Semantic proximity Read ↗

Effect of Hereditary Thrombophilia on the Clinical Severity of Covid-19 PneumoniaSemantic proximity Read ↗

Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19.Semantic proximity Read ↗

Genetic and Epigenetic Intersections in COVID-19-Associated Cardiovascular Disease: Emerging Insights and Future DirectionsSemantic proximity Read ↗

Covid-19-associated coagulopathy (CoAC): thrombin burst and insufficient fibrinolysis leading to bad outcome.Semantic proximity Read ↗

Circulating histones play a central role in COVID-19-associated coagulopathy and mortalitySemantic proximity Read ↗

Contribution of genotypes in Prothrombin and Factor V Leiden to COVID-19 and disease severity in patients at high risk for hereditary thrombophilia.Semantic proximity Read ↗

Identification of potential coagulation pathway abnormalities in SARS-Cov-2 infection; insights from bioinformatics analysisSemantic proximity Read ↗

Differential microRNA expression in the peripheral blood from human patients with COVID‐19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.